• linkedin
  • Increase Font
  • Sharebar

    AUA 2016: Experts offer guidance on the meeting


    Stone Disease

    Dean G. Assimos, MDDr. AssimosDean G. Assimos, MD, and Stephen Y. Nakada, MD, reviewed this year’s stone disease research. Dr. Assimos identified several themes involving percutaneous nephrolithotomy.

    One such theme: “There is evidence that the utilization of PCNL in the United States is increasing,” said Dr. Assimos, professor and chair of urology at the University of Alabama, Birmingham. In addition, Dr. Assimos said this year’s research looks at PCNL’s safety in patients taking aspirin and the usefulness of fusion imaging during PCNL.

    Finally, he said to look for research indicating that the duration of access sheath utilization may impact ureteral stricture risk.

    Here are Dr. Assimos' abstract picks from this year's stone disease program:

    PD18-02: Synchronous Real-time Virtual Sonography with Three-Dimensional Computed Tomography Scan Navigation to create percutaneous renal access to the target calix during percutaneous nephrolithotomy
    Tatsuhiko Hoshii


    PD18-10: Dusting vs Basketing During Ureteroscopic Lithotripsy—What is More Efficacious? Final Results from the EDGE Research Consortium
    Ben Chew


    PD23-01: The Effect of Continued Aspirin Therapy in Patients Undergoing PCNL
    Brandon Otto


    PD23-09: Is prolonged use of ureteral access sheath safe?
    Husain Alenezi


    MP33-09: Contemporary Trends in Percutaneous Nephrolithotomy in the United States: 1998-2011
    Karen Stern


    MP33-11: Anatomical Variations Between Vertical and Horizontal Bolster Placement and the Implications for Percutaneous Nephrolithotomy (PCNL) Access
    Daniel Sagalovich


    Giorgio Bozzini


    MP51-09: Primary versus Deferred Ureteroscopy for Management of Calculus Anuria: A prospective randomized trial
    Mohammed A. Elgammal


    Stephen Y. Nakada, MDDr. NakadaDr. Nakada, professor and chairman of urology at the University of Wisconsin, highlighted several studies that should be of interest to urologists treating stones, including:

    • a look at global trends in urolithiasis morbidity and mortality over a 20-year period
    • a presentation on the effect of statins on kidney stone formation
    • a population-based cohort on extracorporeal shock wave lithotripsy and the risk of diabetes mellitus.

    Here are Dr. Nakada's can't-miss stone disease abstracts from the 2016 annual meeting:

    PD31-10: Statin Intake Reduces Kidney Stone Formation
    Andrew Cohen


    PD47-02: Global Trends in Urolithiasis Morbidity and Mortality from 1990-2010
    David Bayne


    MP54-05: Extracorporeal Shockwave Lithotripsy and the Risk of Diabetes Mellitus: A Population-Based Cohort Study
    Michael Ordon


    MP54-13: Detection and Assessment of Hemorrhagic Kidney Injury Caused by Burst Wave Lithotripsy using Ultrasound and Magnetic Resonance Imaging
    Adam Maxwell


    MP82-09: Metabolic Stone Center Effectively Decreases Emergency Department Visits in High-Risk Patients
    George Turini, III

    Next: Sexual Dysfunction

    Benjamin P. Saylor
    Saylor is content managing editor for Urology Times.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results